Литература:

1. Галстян Г.М., Городецкий В.М. Применение растворов альбумина в клинической практике.// Гематология и трансфузиология. 1993; 5:44-47.

2. Гольдина О.А., Горбачевский Ю.В. Преимущество современных препаратов гидроксиэтилированного крахмала в ряду плазмозамещающих инфузионных растворов.// Вестник службы крови России. 1998; №3: 41-45.

3. Жизневский Я.А. Основы инфузионной терапии. Минск: Выш. шк., 1994, с.205-216.

4. Кассиль В.Л., Лескин Г.С., Выжигина М.А. Общие показания к искусственной вентиляции легких у пациентов в ОРИТ, в Корячкин В.А., Страшнов В.И., Чуфаров В.Н. (ред.): Клинические функциональные и лабораторные тесты в анестезиологии и интенсивной терапии. Санкт-Петербург: Санкт-Петербургское медицинское издательство, 2001, с.54.

5. Крылов В.В., Гусев С.А., и др. Сосудистый спазм при субарахноидальном кровоизлиянии. Клинический атлас. Москва: Макцентр, 2000, с.10-26.

6. Лебедев В.В, Крылов В.В, и др. Хирургия аневризм головного мозга в остром периоде кровоизлияния. Москва: Медицина, 1996, с. 6.

7. Молчанов И.В., Афонин Н.И., и др. Плазмозамещающие растворы на основе желатина–все в прошлом?// Вестник интенсивной терапии, 1999, №3. Инфузионно-трансфузионная терапия.

8. Молчанов И.В., Косаченко В.М., и др. Современные методы применения коллоидных растворов в инфузионно-трансфузионной терапии.// Вестник службы крови России. 1999; №2: 35-40.

9. Молчанов И.В., Михельсон В.А., и др. Современные тенденции в разработке и применении коллоидных растворов в интенсивной терапии.// Вестник службы крови России. 1999; №3: 43-50.

10. Румянцев А.Г., Аграненко В.А. Клиническая трансфузиология. Москва: ГЭОТАР Медицина, 1998, с.188-196.

11. Томмасино К. Инфузионная терапия при пораженном мозге.// Российский журнал анестезиологии и интенсивной терапии. 1999; 2:68-70.

12. Allen G.S., Ahm H.S., et al. Cerebral arterial spasm – a controlled trial of nimodipine in patients with subarachnoid hemorrhage.// N.Engl.J.Med. 1983; 308:619-624.

13. Appel P.L., Shoemaker W.C. Fluid therapy in adult respiratory failure.// Crit. Care Med. 1981; 9:862.

14. Award I.A., Carter L.P., Spetzler R.F., et al. Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension.// Stroke. 1987; 18:365.

15. Baek S.M., Makabali G.G., et al. Plasma expansion in surgical patients with high central venous pressure (CVP); The relationship of blood volume to hematocrit, CVP, pulmonary wedge pressure, and cardiorespiratory changes.// Surgery. 1975; 78:304-315.

16. Belayev L., Liu Y., et al. Human albumin therapy of acute ischemic stroke.// Stroke. 2001; 32:553.

17. Biller J., Toffol G.J., et al. Spontaneous subarachnoid hemorrhage in young adults.// Neurosurg. 1987; 21:664-7.

18. Broderick J.P., Brott T.G., et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage.// J. Neurosurg. 1993; 78:188-91.

19. Camu F., Ivens D., et al. Human albumine and colloid fluid replacement: their use in general surgery.// Acta Anaesthesiol. Belg. 1995; 46:3-18.

20. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials.// BMJ. 1998; 317:235-240.

21. Cortbus F., Steudel W.I. Volume therapy in neurosurgery, in J.Treib (ed.): Volume Therapy. Berlin, Springer-Verlag, 2000, 60-68.

22. Dehne M.G., Muhling J., et al. Effect of hydroxyethyl starch solutions on kidney function in surgical intensive care patients.// Anasthesiol. Intensivmed Notfallmed. 1997; 32:348-354.

23. Findlay J. M. Current management of aneurysmal subarachnoid hemorrhage guidelines from the Canadian Neurosurgical Society.// Can. J. Neurol. Sci. 1997; 24(2):161-70.

24. Hankeln K., et al. Comparison of hydroxyethyl starch and lactated Ringer’s solution on hemodynamics and oxygen transport of critically ill patients in prospective crossover studies.// Crit. Care Med. 1989; 17:133-135.

25. Hankeln K., Senker R., Beez M. Comparative study of the intraoperative efficacy of 5% human albumin and 10% hydroxyethyl starch (HES-steril) in terms of hemodynamics and oxygen transport in 40 patients.// Infusionsther Transfusionsmed. 1990; 17:135-140.

26. Heynkes R. Gelatin without BSE-infectivity can only be produced from healthy animals.// Therapiewoche.1996; 46(29):1818-1820.

27. Hunt W.E., Kosnik E. J. Timing and Perioperative Care in Intracranial Aneurysm Surgery.// Clin. Neurosurg. 1974; 21:79-89.

28. Ingelfinger J.R. Hypertensive emergencies in infants and children, in Shoemaker W.C. et al. (eds): Textbook of Critical Care. W.B.Saunders Company, 2000, 1087-1097.

29. J. van Gijn, Rinkel G.J.E. Subarachnoid hemorrhage: diagnosis, causes and management.// Brain. 2001; 124 (2):249-278.

30. Kapiotis S., et al. Effects of hydroxyethyl starch on blood coagulation and fibrinolisis in healthy volunteers: comparison with albumin.// Crit. Care Med. 1994; 22:606-612.

31. Kassell N.F., Peerless S.J., Durward Q.J., et al. Treatment of ischemic deficits from vasospasm with intravascular expansion and induced arterial hypertension.// Neurosurgery. 1982; 11:337.

32. Kassell N.F., Sasaki T., Colohan A.R., Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage.// Stroke. 1985; 16:562-572.

33. Kassell N.F., Torner J.C., Haley E.C., et al. The International Cooperative Study on the Timing of Aneurysm Surgery, part I: overall management results.// J. Neurosurg. 1990; 73:18-36.

34. Klatzo I., Wisniewski H., et al. Dynamics of cold injury edema, in Klatzo I., Seitelberger F. (eds): Brain Edema. Berlin, Springer-Verlag, 1967, 554-563.

35. Lennihan L., Mayer S.A., Solomon R.A., et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: A randomized controlled trial.// Stroke. 2000; 31:383-391.

36. Ljunggren B., Brandt L., et al. Outcome in 60 consecutive patients treated with early aneurysm operation and intravenous nimodipine.// J. Neurosurg. 1984; 61:864-873.

37. London M.J., Ho J.S., et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.// J. Thorac. Cardiovasc. Surg. 1989; 97:785-797.

38. Marmarou A., Anderson R.L., Ward J.D. Impact of ICP instability and hypotension on outcome in patients with severe head injury.// J. Neurosurg. 1991; 75:S59-S66.

39. Martin N., Khanna R., Rodts G. The intensive care management of patients with subarachnoid hemorrhage, in B.T. Andrews (ed.): Neurosurgical Intensive Care. McGraw-Hill, INC., 1993, 291-310.

40. Matsui T., Sinyama H., et al. Beneficial effect of prolonged administration of albumine on ischemic cerebral edema and infarction after occlusion of middle cerebral artery in rats.// Neurosurgery. 1993; 33:293-300.

41. Mayberg M.R., Batjer H.H., Dacey R., et al. Guidelines for the management of Aneurysmal Subarachnoid Hemorrhage. A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association.// Stroke. 1994; 25:2315-2328.

42. Mayer S.A., Solomon R.A., Fink M.E., et al. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage.// Neurosurgery. 1998; 42:759-768.

43. Miller J.D., Garibi J., et al. Effects of increased arterial pressure on blood flow in the damaged brain.// J. Neurol. Neurosurg. Psychiatry. 1975; 38:657-665.

44. Miller J.D., Stanek A.E., et al. Concepts of cerebral perfusion pressure and vascular compression during intracranial hypertension, in: Cerebral blood flow. Elsevier, Amsterdam, 1982; 35:411-432.

45. Ohkuma H., et al. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management.// Stroke. 2001; 32:1176.

46. Origitano T.C., Wascher T.M., et al. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution («triple-H therapy») after subarachnoid hemorrhage.// Neurosurgery. 1990; 27:729-40.

47. O,Sullivan M.G. Surgical and radiological treatment of sub-arachnoid hemorrhage, in Galley H.F., et al. (eds): Critical Care Focus. Neurological Injury. London, BMJ Books, 2000, 20-27.

48. Pickard J.D., Murray G.D., et al. Oral nimodipine and cerebral ischaemia following subarachnoid hemorrhage.// Br. J. Clin. Pract. 1990; 44:66-67.

49. Pritz M.B. Treatment of cerebral vasospasm: Usefulness of Swan-Ganz Catheter monitoring of volume expansion.// Surg.Neurol. 1984; 21:239-244.

50. Quon Y.C. Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume expanders.// J. Cardiothoracic Anaes. 1988; 2:12-23.

51. Rackow E.C., Mecher C., et al. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion.// Crit. Care Med. 1989; 17:394-398.

52. Reivich M., Marshall W.J.S., et al. Loss of autoregulation produced by cerebral trauma, in Brock M., Feischi C., et al. (eds): Cerebral Blood Flow; Clinical and Experimental Results. Berlin, Springer-Verlag, 1969, 205-208.

53. Roos Y., Rinkel G. et al. Antifibrinolytic Therapy for Aneurysmal Subarachnoid Hemorrhage. A Major Update of a Cochrane Review.// Stroke. 2003; 34:2308.

54. Shah K.B., Rao T.L.K., Laughlin S., et al. A review of pulmonary artery catheterization in 624 patients.// Anesthesiology. 1985; 61:271-275.

55. Shimoda M, Oda S., et al. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm.// J. Neurosurg. 1993; 78(3):423-9.

56. Shoemaker W.C., Kram H.B. Effects of crystalloids and colloids on hemodynamics, oxygen transport and outcome in high-risk surgical patients, in Simmons R.C., Udekuo A.S. (eds): Debates in clinical surgery. Yearbook, Chicago, 1990, 263-316.

57. Solenski N.J., Haley E.C., Kassell N.F., et al. Medical complications of aneurysmal subarachnoid hemorrhage: a report of the multicenter, cooperative aneurysm study.// Crit. Care Med. 1995; 23:1007-17.

58. Strauss R.G. Volume replacement and coagulation: a comparative review.// J. Cardiothoracic Anaes. 1988; 2:24-32.

59. Stump D.C., Strauss R.G., et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII.// Transfusion. 1985; 25:349-354.

60. Tonnessen T. et al. Colloid osmotic pressure replacement fluids.// Acta Anaesthesiologica Scandinavia. 1993; 37:424-426.

61. Treib J., Grauer M.T., Haass A. Efficacy of plasma substitutes for a volume therapy, in J.Treib (ed.): Volume Therapy. Berlin, Springer-Verlag, 2000, 78-122.

62. Treib J., Haass A., et al. Coagulation disorders caused by hydroxyethyl starch.// Thromb. Haemost. 1997; 78:974-983.

63. Trumble E.R., Muizelaar J.P., et al. Coagulopathy with use of hetastarch in the treatment of vasospasm.// J. Neurosurg. 1995; 82:44-47.

64. Weir B.K.,Yoshor D. Early clipping for the treatment of symptomatic vasospasm, in O.Al-Mefty, T.C. Origitano., H.L. Harkey (eds): Controversies in neurosurgery. New York, Thieme, 1996, 189-195.

65. Yonas H. Intracranial Hemorrhage, in Shoemaker W.C. et al. (eds): Textbook of Critical Care. W.B.Saunders Company, 2000, 1866-1875.

66. Zwetnow N. Effects of increased cerebrospinal fluid pressure on the blood flow and on the energy metabolism of the brain.// Acta Physiol. Scand. 1970; 339:1-31.

Возврат к протоколу